Vitamin D attenuates cytokine-induced remodeling in human fetal airway smooth muscle cells.
Ontology highlight
ABSTRACT: Asthma in the pediatric population remains a significant contributor to morbidity and increasing healthcare costs. Vitamin D3 insufficiency and deficiency have been associated with development of asthma. Recent studies in models of adult airway diseases suggest that the bioactive Vitamin D3 metabolite, calcitriol (1,25-dihydroxyvitamin D3 ; 1,25(OH)2 D3 ), modulates responses to inflammation; however, this concept has not been explored in developing airways in the context of pediatric asthma. We used human fetal airway smooth muscle (ASM) cells as a model of the early postnatal airway to explore how calcitriol modulates remodeling induced by pro-inflammatory cytokines. Cells were pre-treated with calcitriol and then exposed to TNF? or TGF? for up to 72?h. Matrix metalloproteinase (MMP) activity, production of extracellular matrix (ECM), and cell proliferation were assessed. Calcitriol attenuated TNF? enhancement of MMP-9 expression and activity. Additionally, calcitriol attenuated TNF? and TGF?-induced collagen III expression and deposition, and separately, inhibited proliferation of fetal ASM cells induced by either inflammatory mediator. Analysis of signaling pathways suggested that calcitriol effects in fetal ASM involve ERK signaling, but not other major inflammatory pathways. Overall, our data demonstrate that calcitriol can blunt multiple effects of TNF? and TGF? in developing airway, and point to a potentially novel approach to alleviating structural changes in inflammatory airway diseases of childhood.
SUBMITTER: Britt RD
PROVIDER: S-EPMC4344421 | biostudies-literature | 2015 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA